bluebird bio, Inc. (BLUE) - יתרות מזומנים בחישוב למניה

Cash per share trends on the GURU.Markets terminal chart demonstrate the issuer's liquidity, where 8.01 serves as the final level mark. The rise in bluebird bio, Inc. (BLUE) quotes is supported by the expansion of insurance coverage and sales of Lyfgenia and Zynteglo. The company corrects defective cells in a single session, offering a revolutionary treatment method. The current product portfolio ensures commercial development in anemia therapy.
פילוחי מדדים מקיפים ואנליטיקה עבור bluebird bio (BLUE)

bluebird bio, Inc. (BLUE) holds a leading position in the gene therapy sector, possessing exceptional pricing power. This indicator determines the volume of liquid assets per common share, reflecting the actual financial reserve. By analyzing the cash per share calculation, an investor assesses the business's ability to sustain operational activities. The company's high gross margin ensures a steady inflow of capital. Such a foundation confirms the long-term sustainability of the business.